论文部分内容阅读
目的评价无水乙醇化学消融治疗少血供肝癌的临床疗效。方法经过介入造影后肿瘤为少血供并无碘油沉积或沉积不良的肝癌患者,采用在影像学监视下经皮肝穿注射化学消融剂(PEI),术后检测AFP或CT、MRI等,进行疗效评价。结果术后1年复查,7例出现局灶复发和远处转移,占8.5%,死亡20例,占24.4%,55例患者肿瘤得到有效控制,占67.1%,即1年内生存率为67.1%。结论少血供肝癌经过化学消融治疗是一种有效的治疗手段。
Objective To evaluate the clinical efficacy of anhydrous ethanol chemical ablation in the treatment of less blood supply of liver cancer. [Methods] After interventional angiography, the tumor was treated with percutaneous transhepatic injection of chemical ablative agent (PEI) under imaging monitoring, AFP, CT, MRI and so on. Efficacy evaluation. Results One year after operation, 7 cases showed focal recurrence and distant metastasis, accounting for 8.5%, 20 cases died, accounting for 24.4%. The tumor was effectively controlled in 55 cases (67.1%), that is, the survival rate in 1 year was 67.1% . Conclusion Blood donation for liver cancer after chemotherapy is an effective treatment.